TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
29 hedge funds and large institutions have $14.9M invested in Trillium Therapeutics Inc. in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$565K | |
| 2 | +$313K | |
| 3 | +$143K | |
| 4 |
PCM
Prelude Capital Management
New York
|
+$131K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$127K |
Top Sellers
| 1 | -$5.46M | |
| 2 | -$4.43M | |
| 3 | -$2.55M | |
| 4 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
-$2.17M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.96M |